0 45 Vioxx : Slightly Bigger Deal than we Thought ?
 (ROOT (NP (NP (NN Vioxx)) (: :) (NP (NP (RB Slightly) (JJR Bigger) (NN Deal)) (SBAR (IN than) (S (NP (PRP we)) (VP (VBZ Thought))))) (. ?)))
46 155 Byrne 2005-01-26T07 :11:00 Merck posted a 21 % decline in earnings thanks to the new post-Vioxx announcement .
 (ROOT (S (NP (NNP Byrne) (NN 2005-01-26T07) (NNP :11:00) (NNP Merck)) (VP (VBD posted) (NP (NP (DT a) (ADJP (CD 21) (NN %)) (NN decline)) (PP (IN in) (NP (NNS earnings)))) (ADVP (NNS thanks) (PP (TO to) (NP (DT the) (JJ new) (JJ post-Vioxx) (NN announcement))))) (. .)))
156 407 Most of the profit decline was because Vioxx , representing about 11 % of sales , now represents a pretty severe legal headache : Not only have they lost the revenue , but they 've taken a $ 600 million charge as a reserve against future Vioxx losses .
 (ROOT (S (S (NP (NP (JJS Most)) (PP (IN of) (NP (DT the) (NN profit) (NN decline)))) (VP (VBD was) (SBAR (IN because) (S (NP (NP (NNP Vioxx)) (, ,) (VP (VBG representing) (NP (NP (QP (RB about) (CD 11)) (NN %)) (PP (IN of) (NP (NNS sales))))) (, ,)) (ADVP (RB now)) (VP (VBZ represents) (NP (DT a) (ADJP (RB pretty) (JJ severe)) (JJ legal) (NN headache))))))) (: :) (S (NP (RB Not) (RB only)) (VP (VBP have) (S (S (NP (PRP they)) (VP (VBD lost) (NP (DT the) (NN revenue)))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBP 've) (VP (VBN taken) (NP (DT a) (ADJP (QP ($ $) (CD 600) (CD million))) (NN charge)) (PP (IN as) (NP (NP (DT a) (NN reserve)) (PP (IN against) (NP (JJ future) (NN Vioxx) (NNS losses))))))))))) (. .)))
408 592 If that 's an accurate number , investors should cheer up : Merck 's at fifteen times annualized earnings , twelve times forward earnings , and underappreciated by most of Wall Street .
 (ROOT (S (S (SBAR (IN If) (S (NP (DT that)) (VP (VBZ 's) (NP (DT an) (ADJP (JJ accurate)) (NN number))))) (, ,) (NP (NNS investors)) (VP (MD should) (VP (VB cheer) (PRT (RP up))))) (: :) (S (NP (NNP Merck)) (VP (VP (VBZ 's) (PP (IN at) (NP (NN fifteen) (NNS times))) (NP (NP (JJ annualized) (NNS earnings)) (, ,) (ADVP (NP (CD twelve) (NNS times)) (RB forward)) (NP (NNS earnings)))) (, ,) (CC and) (VP (VBD underappreciated) (PP (IN by) (NP (NP (JJS most)) (PP (IN of) (NP (NNP Wall) (NNP Street)))))))) (. .)))
593 623 Full Disclosure : I own Merck .
 (ROOT (NP (NP (JJ Full) (NN Disclosure)) (: :) (NP (CD I) (JJ own) (NP (NNP Merck))) (. .)))
624 667 I bought the day of the Vioxx announcement .
 (ROOT (S (NP (PRP I)) (VP (VBD bought) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (DT the) (NNP Vioxx) (NN announcement))))) (. .)))
668 819 And if I want to stay that contrarian , I 'll have to sell only when I get an inside tip that they 've cured cancer , AIDS , heart disease , and death .
 (ROOT (S (CC And) (SBAR (IN if) (S (NP (PRP I)) (VP (VBP want) (S (VP (TO to) (VP (VB stay) (S (NP (DT that)) (ADJP (JJ contrarian))))))))) (, ,) (NP (PRP I)) (VP (MD 'll) (VP (VB have) (S (VP (TO to) (VP (VB sell) (ADVP (RB only)) (SBAR (WHADVP (WRB when)) (S (NP (PRP I)) (VP (VBP get) (NP (DT an) (JJ inside) (NN tip)) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP 've) (VP (VBN cured) (NP (NP (NN cancer)) (, ,) (NP (NN AIDS)) (, ,) (NP (NN heart) (NN disease)) (, ,) (CC and) (NP (NN death))))))))))))))) (. .)))
820 1085 J. Nathan ???? - ?? - ?? T19 :49:00 If you read the quarterly more carefully , you 'll notice that the charge is not related to liabilities from Vioxx but merely costs associated with legal defense , i.e. , just the cost of paying the lawyers in all of these cases .
 (ROOT (NP (NP (NNP J.) (NNP Nathan) (NNP ????)) (: -) (S (S (ADJP (ADJP (JJ ??)) (: -) (NP (NP (NN ??) (NN T19) (CD :49:00)) (SBAR (S (SBAR (IN If) (S (NP (PRP you)) (VP (VBD read) (NP (DT the) (NN quarterly)) (ADVP (RBR more) (RB carefully))))) (, ,) (NP (PRP you)) (VP (MD 'll) (VP (VB notice) (SBAR (IN that) (S (NP (DT the) (NN charge)) (VP (VBZ is) (RB not) (ADJP (JJ related) (PP (TO to) (NP (NP (NP (NNS liabilities)) (PP (IN from) (NP (NNP Vioxx)))) (CONJP (CC but) (RB merely)) (NP (NP (NNS costs)) (VP (VBN associated) (PP (IN with) (NP (JJ legal) (NN defense)))))))))))))))))) (, ,) (FW i.e.) (, ,) (S (NP (NP (RB just) (DT the) (NN cost)) (PP (IN of) (S (VP (VBG paying) (NP (DT the) (NNS lawyers)) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (DT these) (NNS cases))))))))))) (. .)))
1086 1201 If thats how much they 're willing to pay for legal defense , imagine how much the actual liabilities are gonna be .
 (ROOT (S (SBAR (IN If) (S (VP (VBZ thats) (SBAR (WHADJP (WRB how) (JJ much)) (S (NP (PRP they)) (VP (VBP 're) (ADJP (JJ willing) (S (VP (TO to) (VP (VB pay) (PP (IN for) (NP (JJ legal) (NN defense))))))))))))) (, ,) (VP (VB imagine) (SBAR (WHADJP (WRB how) (JJ much)) (S (NP (DT the) (JJ actual) (NNS liabilities)) (VP (VBP are) (VP (VBG gonna) (VP (VB be))))))) (. .)))
1202 1247 Good blog , I found you via your instalanche .
 (ROOT (S (S (ADJP (JJ Good) (NN blog))) (, ,) (NP (PRP I)) (VP (VBD found) (NP (PRP you)) (PP (IN via) (NP (PRP$ your) (NN instalanche)))) (. .)))
1248 1308 Byrne ???? - ?? - ?? T22 :43:00 Thanks for your compliments .
 (ROOT (NP (NP (NNP Byrne) (NNP ????)) (: -) (NP (NP (NN ??)) (: -) (NP (NP (NN ??) (NN T22)) (PP (NP (CD :43:00) (NNS Thanks)) (IN for) (NP (PRP$ your) (NNS compliments))))) (. .)))
1309 1414 Usually , I do n't read the filings as carefully as I should -- I leave it up to alert readers , I guess .
 (ROOT (S (S (S (ADVP (RB Usually)) (, ,) (NP (PRP I)) (VP (VBP do) (RB n't) (VP (VB read) (NP (DT the) (NNS filings)) (ADVP (ADVP (RB as) (RB carefully)) (SBAR (IN as) (S (NP (PRP I)) (VP (MD should)))))))) (: --) (S (NP (PRP I)) (VP (VBP leave) (NP (PRP it)) (PRT (RP up)) (PP (TO to) (NP (JJ alert) (NNS readers)))))) (, ,) (NP (PRP I)) (VP (VBP guess)) (. .)))
1415 1748 Anyway , I still think the Vioxx risk is overestimated -- if the tobacco industry can sell something with no health benefits for years , get sued , and 1 -RRB- Keep the product on the shelves , 2 -RRB- Remain in business , and 3 -RRB- do 2 -RRB- to the tune of several billion dollars per year in profits , we Merckers might be safe .
 (ROOT (S (S (ADVP (RB Anyway)) (, ,) (NP (PRP I)) (ADVP (RB still)) (VP (VBP think) (SBAR (S (NP (DT the) (NNP Vioxx) (NN risk)) (VP (VBZ is) (VP (VBN overestimated))))))) (: --) (S (SBAR (IN if) (S (NP (DT the) (NN tobacco) (NN industry)) (VP (MD can) (VP (VP (VB sell) (NP (NN something)) (PP (IN with) (NP (NP (DT no) (NN health) (NNS benefits)) (PP (IN for) (NP (NNS years)))))) (, ,) (VP (VB get) (VP (VBN sued))) (, ,) (CC and) (VP (LST (LS 1) (-RRB- -RRB-)) (VB Keep) (NP (DT the) (NN product)) (PP (IN on) (NP (NP (DT the) (NNS shelves)) (, ,) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (NNP Remain)) (PP (IN in) (NP (NN business)))) (, ,) (CC and) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (VP (VB do) (NP (CD 2)) (-RRB- -RRB-) (PP (TO to) (NP (NP (DT the) (NN tune)) (PP (IN of) (NP (QP (JJ several) (CD billion)) (NNS dollars)))))) (PP (IN per) (NP (NP (NN year)) (PP (IN in) (NP (NNS profits)))))))))))))) (, ,) (NP (PRP we) (NNPS Merckers)) (VP (MD might) (VP (VB be) (ADJP (JJ safe))))) (. .)))
1748 1748 .
 (ROOT (NP (NNP .)))
